Skip to main content

Paul Anthony Polansky, BSPharm, MBA

Executive VP & Chief Pharmacy Officer
Sanovia Corporation
Philadelphia, PA 

Authored Items
Chronic Obstructive Pulmonary Disease: An Overview
John F. Devine, DO, FACP, Paul Anthony Polansky, BSPharm, MBA
September 2008, Vol 1, No 7 in Original Research
Partial Compliance with Antipsychotics Increases Mental Health Hospitalizations in Schizophrenic Patients: Analysis of a National Managed Care Database
Chris M. Kozma, PhD, Paul Anthony Polansky, BSPharm, MBA, Peter J. Weiden, MD
January 2009, Vol 2, No 1 in Original Research
Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers
Melinda C. Haren, RN, Paul Anthony Polansky, BSPharm, MBA, Kirk McConnell, Arthur F. Shinn, PharmD, FASCP
April/May 2009, Vol 2, No 3 in Practice Management
Economic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic Rhinitis
Kim Saverno, PhD, Paul Anthony Polansky, BSPharm, MBA, Brian Seal, PhD, Michael J. Goodman, PhD, Kellie Meyer, PharmD
November/December 2009, Vol 2, No 7 in Original Research
Last modified: September 6, 2013